Recent Gains in Clinical Multiple Sclerosis Research

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|11|5|497-505

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.11, Iss.5, 2012-08, pp. : 497-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Research Highlights: Clinical relevance of the type I interferon signature in multiple sclerosis

By Verweij Cornelis L  

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1883-1885

Future Medicine

Access to resources Recommend Favorite

Recent advances in preclinical drug development in multiple sclerosis

By Hoban C.J.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 831-854

Informa Healthcare

Access to resources Recommend Favorite

Drugs in Clinical Development for Multiple Sclerosis: Summary and Table

By  

Pharmaceutical Medicine, Vol. 26, Iss. 2, 2012-04 ,pp. : 103-112

Adis International

Access to resources Recommend Favorite

Multiple Sclerosis In Childhood and Adolescence: Clinical Features and Management

By Pinhas-Hamiel O.   Sarova-Pinhas I.   Achiron A.  

Pediatric Drugs, Vol. 3, Iss. 5, 2001-01 ,pp. : 329-336

Adis International

Access to resources Recommend Favorite

Disease-Modifying Agents for Multiple Sclerosis: Recent Advances and Future Prospects

By Menge Til  

Drugs, Vol. 68, Iss. 17, 2008-01 ,pp. : 2445-2468

Adis International

Access to resources Recommend Favorite